P

Inventor

ALI AMJAD

US70 patents
⚠️ This page may combine multiple inventors who share the name “ALI AMJAD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK SHARP & DOHME

29 patents
US8053455B2Nov 8, 2011

Angiotensin II receptor antagonists

MERCK SHARP & DOHME28 citations91
US7947664B2May 24, 2011

Angiotensin II receptor antagonists

MERCK SHARP & DOHME28 citations90
US8354454B2Jan 15, 2013

Prodrugs of oxazolidinone CETP inhibitors

MERCK SHARP & DOHME7 citations84
US7915271B2Mar 29, 2011

1,3-oxazolidin-2-one derivatives useful as CETP inhibitors

MERCK SHARP & DOHME15 citations84
US7910592B2Mar 22, 2011

CETP inhibitors

MERCK SHARP & DOHME13 citations84
US7781426B2Aug 24, 2010

CETP inhibitors

MERCK SHARP & DOHME18 citations82
US7737295B2Jun 15, 2010

CETP inhibitors

MERCK SHARP & DOHME15 citations82
US10472347B2Nov 12, 2019

Aminopyrazine compounds with A2A antagonist properties

MERCK SHARP & DOHME5 citations72
US10123995B2Nov 13, 2018

Factor XIa inhibitors

MERCK SHARP & DOHME2 citations72
US10011585B2Jul 3, 2018

Factor XIa inhibitors

MERCK SHARP & DOHME2 citations72
US9868727B2Jan 16, 2018

Factor XIa inhibitors

MERCK SHARP & DOHME3 citations72
US9783530B2Oct 10, 2017

Factor Xla inhibitors

MERCK SHARP & DOHME2 citations72
US9708347B2Jul 18, 2017

Heterobicyclo-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties

MERCK SHARP & DOHME3 citations72
US10822338B2Nov 3, 2020

Substituted aminoquinazoline compounds as A2A antagonist

MERCK SHARP & DOHME2 citations71
US10093683B2Oct 9, 2018

Factor XIa inhibitors

MERCK SHARP & DOHME4 citations71
US10011615B2Jul 3, 2018

Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties

MERCK SHARP & DOHME3 citations71
US11312719B2Apr 26, 2022

9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use

MERCK SHARP & DOHME4 citations70
US10138212B2Nov 27, 2018

Aminoquinazoline compounds as A2A antagonist

MERCK SHARP & DOHME2 citations70
US10081617B2Sep 25, 2018

Factor XIa inhibitors

MERCK SHARP & DOHME2 citations70
US10344039B2Jul 9, 2019

Macrocyclic spirocarbamate derivatives as factor XIa inhibitors, pharmaceutically acceptable compositions and their use

MERCK SHARP & DOHME1 citations62
US8361994B2Jan 29, 2013

Primary amine diazeniumdiolate heterocyclic derivatives

MERCK SHARP & DOHME2 citations62
US7834042B2Nov 16, 2010

Angiotensin II receptor antagonists

MERCK SHARP & DOHME3 citations62
US7732432B2Jun 8, 2010

17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators

MERCK SHARP & DOHME4 citations62
US9676780B2Jun 13, 2017

Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties

MERCK SHARP & DOHME2 citations61
US7880014B2Feb 1, 2011

Angiotensin II receptor antagonists

MERCK SHARP & DOHME2 citations61
US7745657B2Jun 29, 2010

D-homoandrosta-17-yl carbamate derivatives as selective glucocorticoid receptor ligands

MERCK SHARP & DOHME4 citations60
US8377911B2Feb 19, 2013

Diuretics

MERCK SHARP & DOHME0 citations52
US8367711B2Feb 5, 2013

Angiotensin II receptor antagonists

MERCK SHARP & DOHME0 citations51
US8354394B2Jan 15, 2013

Diuretics

MERCK SHARP & DOHME0 citations51

ALI AMJAD

9 patents

MERCK & CO INC

4 patents

MERCK SHARP & DOHME LLC

4 patents

DESCHENES DENIS

1 patent

GEN MOTORS CORP

1 patent

HOYT SCOTT B

1 patent

UNIV KING FAHD PET & MINERALS

1 patent

Showing the top 50 of 70 patents by PatentIndex Score.